Shibo Cheng

Dr. Shibo Cheng


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2025 in Lab on a Chip
Verified
Journal Article
Closed access
PDF file
YZYu-Xin Zhang
Yu-Xin Zhang
MWMing Wang
Ming Wang
LXLi-Li Xu
Li-Li Xu
YCYi-Jing Chen
Yi-Jing Chen
SZShu-Ting Zhong
Shu-Ting Zhong
WHWeihua Huang
Weihua Huang
A microfluidic chip integrating a 3D macroporous scaffold and magnetoresponsive electrode achieves exosome isolation, electrochemical detection, and doxorubicin loading, offering a seamless platform for analysis and therapeutic delivery.

25 December 2024 in Advanced Science
Verified
Journal Article
Open access
YBYi‐Ru Bao
Yi‐Ru Bao
YCYi‐Jing Chen
Yi‐Jing Chen
XDXue‐Fan Deng
Xue‐Fan Deng
YWYi‐Ke Wang
Yi‐Ke Wang
YZYu‐Xin Zhang
Yu‐Xin Zhang
MXMin Xie
Min Xie
Exosome‐based drug delivery holds significant promise for cancer chemotherapy. However, current methods for loading drugs into exosomes are inefficient and cost‐prohibitive for practical application. In this study, boron clusters are mixed with doxorubicin (DOX) and exosomes, enabling the efficient encapsulation of DOX into exosomes through a superchaotropic effect. Exosomes loaded with DOX and boron clusters (EDB) exhibit superior permeability and the ability to deliver higher concentrations of DOX into DOX‐resistant breast cancer cells. Mechanistic analysis reveals that boron clusters form a supramolecular complex with DOX, which facilitates sustained drug release and effectively inhibits P‐glycoprotein‐mediated DOX efflux. As a result, EDB significantly enhance apoptosis in DOX‐resistant breast cancer cells and suppress tumor growth in cases where DOX alone is ineffective, thereby extending the survival of nude mice. In summary, boron clusters effectively facilitate the incorporation of DOX into exosomes and inhibit DOX efflux, offering a novel strategy to overcome DOX resistance.

17 March 2026 in Advanced Science
Verified
Journal Article
Open access
YWYi‐Ke Wang
Yi‐Ke Wang
MWMing Wang
Ming Wang
MLMin Liu
Min Liu
YCYi‐Jing Chen
Yi‐Jing Chen
LXLi‐Li Xu
Li‐Li Xu
WHWeihua Huang
Weihua Huang
Patient‐derived xenograft (PDX) models constructed by noninvasively accessible circulating tumor cells (CTCs) serve as pivotal and invaluable tools for oncology research and precision medicine. However, the rarity of CTCs in blood and their limited proliferation ability present significant challenges for establishing patient CTC‐derived xenograft (CDX) models. In this study, a novel 3D cellulose scaffold is developed for efficient isolation and in situ culture of CTCs, with the aim of constructing CDX models. Characterized by a macroporous and flexible structure, the 3D cellulose scaffold achieves high‐efficiency CTC capture while maintaining cell viability. Its excellent biocompatibility and permeability further promote the rapid and in situ growth of CTCs. Importantly, the self‐supporting and biodegradable scaffold allows for direct implantation into immunodeficient mice without leaving any residual material. This 3D cellulose scaffold has been successfully employed to construct CDX models from breast cancer patients. The application of this platform may enhance our understanding of metastasis mechanisms and offer significant benefits for cancer therapy.

31 July 2026 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
JZJunchi Zhong
Junchi Zhong
QZQiang Zhao
Qiang Zhao
BYBiru Yang
Biru Yang
LTLina Tang
Lina Tang
SCShibo Cheng
Shibo Cheng
YLyutao Li
yutao Li